Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Orasure Tech Inc (OSUR)

Orasure Tech Inc (OSUR)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 825,943
  • Shares Outstanding, K 72,009
  • Annual Sales, $ 171,720 K
  • Annual Income, $ -14,920 K
  • 60-Month Beta -0.28
  • Price/Sales 4.42
  • Price/Cash Flow N/A
  • Price/Book 1.99
Trade OSUR with:

Options Overview

Details
  • Implied Volatility 77.31%
  • Historical Volatility 55.10%
  • IV Percentile 31%
  • IV Rank 27.39%
  • IV High 122.61% on 10/14/20
  • IV Low 60.22% on 08/12/21
  • Put/Call Vol Ratio 0.16
  • Today's Volume 2,473
  • Volume Avg (30-Day) 280
  • Put/Call OI Ratio 0.46
  • Today's Open Interest 6,413
  • Open Int (30-Day) 4,955

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/21
See More
  • Average Estimate -0.05
  • Number of Estimates 3
  • High Estimate -0.01
  • Low Estimate -0.10
  • Prior Year 0.01
  • Growth Rate Est. (year over year) -600.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
10.03 +14.36%
on 08/20/21
11.85 -3.21%
on 09/10/21
+0.94 (+8.93%)
since 08/16/21
3-Month
9.02 +27.16%
on 06/21/21
12.41 -7.57%
on 08/03/21
+2.08 (+22.15%)
since 06/16/21
52-Week
8.58 +33.68%
on 05/06/21
17.79 -35.53%
on 10/19/20
+0.33 (+2.96%)
since 09/16/20

Most Recent Stories

More News
Therapeutic Drug Monitoring Market Offered in New Research Forecasted through 2027

Research Nester released a report titled ": Global Demand Analysis & Opportunity Outlook 2029" which delivers detailed overview of the therapeutic drug monitoring market in terms of market segmentation...

ABT : 127.44 (-0.04%)
TMO : 560.44 (-0.45%)
BIO : 785.22 (-0.62%)
OSUR : 11.47 (+8.72%)
Therapeutic Drug Monitoring Market to Drive Amazing Growth by 2029

Research Nester released a report titled ": Global Demand Analysis & Opportunity Outlook 2029" which delivers detailed overview of the therapeutic drug monitoring market in terms of market segmentation...

ABT : 127.44 (-0.04%)
TMO : 560.44 (-0.45%)
BIO : 785.22 (-0.62%)
OSUR : 11.47 (+8.72%)
HIV Diagnostics Market Revenue to Cross USD 760 Mn by 2027: Global Market Insights Inc.

/PRNewswire/ -- According to the latest report, , by Global Market Insights Inc.,  will cross by 2027. Technological improvements and the increasing prevalence of HIV in developing and underdeveloped...

ABT : 127.44 (-0.04%)
CPHD : 52.95 (unch)
CEMI : 2.68 (+2.68%)
OSUR : 11.47 (+8.72%)
OraSure Technologies (OSUR) Reports Q2 Loss, Tops Revenue Estimates

OraSure (OSUR) delivered earnings and revenue surprises of -150.00% and 1.96%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

OSUR : 11.47 (+8.72%)
OraSure Technologies Reports 2Q21 Revenue of $57.6 Million Driven by Strong Rebound in Core Business

-- Excluding COVID-19 product revenues, revenues for the second quarter grew 122% YoY and 48% sequentially as the Company's core business began to return to pre-pandemic revenue levels

OSUR : 11.47 (+8.72%)
Slone Partners Places Scott Gleason as Senior Vice President Investor Relations and Corporate Communications at OraSure Technologies

/PRNewswire-PRWeb/ -- , a nationwide executive search firm for life sciences, biotechnology, and diagnostics companies, has announced the placement of as Senior Vice President Investor Relations and Corporate...

MYGN : 32.62 (-0.31%)
OSUR : 11.47 (+8.72%)
OraSure Technologies (OSUR) Earnings Expected to Grow: What to Know Ahead of Q2 Release

OraSure (OSUR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

OSUR : 11.47 (+8.72%)
OraSure Technologies, Inc. to Hold 2021 Second Quarter Earnings Conference Call Tuesday, August 3, 2021, 5:00 p.m. ET

OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering 2021 second quarter financial results and certain business developments for 5:00 pm ET (2:00 pm PT)...

OSUR : 11.47 (+8.72%)
OraSure Technologies to Present at the Raymond James 2021 Human Health and Innovation Conference

OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point of care diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services, today announced that Dr. Stephen S....

OSUR : 11.47 (+8.72%)
New Life-Changing Test for Patients Diagnosed With Peanut Allergy

/PRNewswire/ -- , a predictive data analytics company specializing in the detection and management of life-threatening immune response disorders including food allergy, announced the publication of a...

OSUR : 11.47 (+8.72%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 32% Buy with a Strengthening short term outlook on maintaining the current direction.

See More Share

Business Summary

OraSure Technologies, Inc. develops, manufactures and markets oral fluid specimen collection devices using proprietary oral fluid technologies, diagnostic products including immunoassays and other in vitro diagnostic tests, and other medical devices. These products are sold in the United States as well...

See More

Key Turning Points

3rd Resistance Point 12.99
2nd Resistance Point 12.30
1st Resistance Point 11.89
Last Price 11.47
1st Support Level 10.79
2nd Support Level 10.10
3rd Support Level 9.69

See More

52-Week High 17.79
Fibonacci 61.8% 14.27
Fibonacci 50% 13.19
Fibonacci 38.2% 12.10
Last Price 11.47
52-Week Low 8.58

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar